New Trend Analysis Report Issued For: Avanir Pharmaceuticals Inc (NASDAQ:AVNR), KBridge Energy Corp (OTCMKTS:BMMCF)

New York, NY – (NISMAGAZINE) –08/29/2013- Avanir Pharmaceuticals Inc (NASDAQ:AVNR) shot up 4.88% at $5.16 after trading 2.56 million shares. On Tuesday Piper Jaffray hiked their price target on the stock from $6.00 to $13.00 and maintained an Overweight rating on the stock. According to the analysts, the company’s AVP-786 drug could have the edge over Nuedexta generics in the treatment of Alzheimer’s disease, Multiple Sclerosis, PD and autism. Yesterday the stock formed a bullish engulfing pattern and it appears the stock is well positioned to continue in its ascending channel.

Is AVNR a solid investment at these levels? Get valuable insight and must-know updates here.

KBridge Energy Corp (OTCMKTS:BMMCF) crashed 72.41% at $0.0800 after trading 3.36 million shares. It is a development stage company that provides consulting services in South Korea. It operates as a broker for energy and resource related contracts. The company was formerly known as Blue Marble Media Corp. and changed its name to Kbridge Energy Corp. in December 2011. No recent quarterly data is available on the company’s finances. However, for the year ended December 31, 2012, the company reported revenue of $461K and a net income of $206K. As on that date it reported cash and cash equivalents of $72K and current liabilities of $280K.

How Should Investors Trade BMMCF Now? Check out this exclusive report!


Subscribe for FREE to receive our “50 Stock Trading Rules No Hedge Fund Wants You To Know!” E-Book: continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.

Disclosure: is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit website, for complete risks and disclosures.


Gale Wills


Leave a Comment